New test will run on Abbott's Alinity® i laboratory instrument, complementing Abbott's rapid i-STAT TBI Plasma test, cleared by the FDA in 2021 Given the significant number of Alinity i instruments in ...
Chicago, IL – December 8, 2021 – Today, Zacks Equity Research discusses Medical Products, including Abbott Laboratories ABT, Bio-Rad Laboratories, Inc. BIO and ...
Abbott Labs ABT handily beat wall street estimates with Q4 sales of $11.4 billion beating the forecast of $10.7 billion, but then provided weak 2022 guidance on COVID-19 testing, citing an uncertain ...
On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback